These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita. Tukaj S; Mantej J; Sitko K; Zillikens D; Ludwig RJ; Bieber K; Kasperkiewicz M Front Immunol; 2022; 13():877958. PubMed ID: 35514963 [TBL] [Abstract][Full Text] [Related]
37. Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. Wen L; Dong X; Li Q; Schramm G; Zhang B; Zillikens D; Ludwig RJ; Petersen F; Yu X Front Immunol; 2021; 12():750160. PubMed ID: 34712239 [TBL] [Abstract][Full Text] [Related]
38. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Stewart MI; Woodley DT; Briggaman RA Arch Dermatol; 1991 Mar; 127(3):373-7. PubMed ID: 1998368 [TBL] [Abstract][Full Text] [Related]
39. Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients. Barreiro-Capurro A; Mascaró-Galy JM; Iranzo P Actas Dermosifiliogr; 2013 Dec; 104(10):904-14. PubMed ID: 23895729 [TBL] [Abstract][Full Text] [Related]
40. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]